Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Contact us to discover how Methylene Blue IV therapy could benefit you or your loved ones.
Notably, older adults are more likely than their younger peers to have been told by a doctor that they have diabetes or heart disease
Lancet Diabetes Endocrinol (2019) 7:83444
Your dose may increase over time to reach therapeutic effect, but your price remains flat, allowing you to focus on tolerance and lifestyle adjustments rather than cost concerns
Recommendation : Bundle GLP-1 coverage with a medication therapy management (MTM), digital or onsite wellness program
- solving real issue ( address the significant unmet needs of patients) -Timing (first mover advantage) - Packaging ( coming up with vials because they were not getting pens in India) - Positioning ( originated as diabetes drugs, Lilly took a bold step in repositioning as weight-loss and obesity therapy first, not a diabetes injection) - execution ( steady representative in comparison to competition)
US$ 22.76
US$ 26.07
US$ 22.86
US$ 21.95
US$ 26.04
US$ 22.97
US$ 27.13
